Search bioRxiv⌕ Search

Biology subjects

Lane, H.

Publications and source records attributed to Lane, H..

2 recordsLinked to original sources

Assessment of lisavanbulin (BAL101553) as an anti-lymphoma agent

Microtubules are major components of the cellular cytoskeleton, ubiquitously founded in all eukaryotic cells. They are involved in mitosis, cell motility, intracellular protein and organelle transport, and maintenance of cytoskeletal shape. Avanbulin (BAL27862) is a microtubule-targeted agent (MTA) that promotes tumor cell death by destabilization of microtubules. Due to its unique binding to the colchicine site of tubulin, differently from other MTAs, avanbulin has previously shown activity in solid tumor cell lines. Its prodrug, lisavanbulin (BAL101553), has shown early signs of clinical activity, especially in tumors with high EB1 expression. Here, we assessed the preclinical anti-tumor activity of avanbulin in diffuse large B cell lymphoma (DLBCL) and the pattern of expression of EB1 in DLBCL cell lines and clinical specimens. Avanbulin showed a potent in vitro anti-lymphoma activity, which was mainly cytotoxic with potent and rapid apoptosis induction. Median IC50 was around 10nM in both activated B cell like (ABC) and germinal center B cell like (GCB) DLBCL. Half of the cell lines tested showed an induction of apoptosis already in the first 24h of treatment, the other half in the first 48h. EB1 showed expression in DLBCL clinical specimens, opening the possibility for a cohort of patients that could potentially benefit from treatment with lisavanbulin. These data show the basis for further preclinical and clinical evaluation of lisavanbulin in the lymphoma field.

cancer biology↗

Predicting response to motor therapy in chronic stroke patients using Machine Learning

Accurate predictions of motor improvement resulting from intensive therapy in chronic stroke patients is a difficult task for clinicians, but is key in prescribing appropriate therapeutic strategies. Statistical methods, including machine learning, are a highly promising avenue with which to improve prediction accuracy in clinical practice. The first main objective of this study was to use machine learning methods to predict a chronic stroke individuals motor function improvement after 6 weeks of intervention using pre-intervention demographic, clinical, neurophysiological and imaging data. The second main objective was to identify which data elements were most important in predicting chronic stroke patients impairment after 6 weeks of intervention. Data from one hundred and two patients (Female: 31%, age 61{+/-}11 years) who suffered first ischemic stroke 3-12 months prior were included in this study. After enrollment, patients underwent 6 weeks of intensive motor and transcranial magnetic stimulation therapy. Age, gender, handedness, time since stroke, pre-intervention Fugl-Meyer Assessment, stroke lateralization, the difference in motor threshold between the unaffected and affected hemispheres, absence or presence of motor evoked potential in the affected hemisphere and various imaging metrics were used as predictors of post-intervention Fugl-Meyer Assessment. Five machine learning methods, including Elastic-Net, Support Vector Machines, Artificial Neural Networks, Classification and Regression Trees, and Random Forest, were used to predict post-intervention Fugl-Meyer Assessment based on either demographic, clinical and neurophysiological data alone or in combination with the imaging metrics. Cross-validated R-squared and root of mean squared error were used to assess the prediction accuracy and compare the performance of methods. Elastic-Net performed significantly better than the other methods for the model containing pre-intervention Fugl-Meyer Assessment, demographic, clinical and neurophysiological data as predictors of post-intervention Fugl-Meyer Assessment ([Formula]). Pre-intervention Fugl-Meyer Assessment and difference in motor threshold between affected and unaffected hemispheres were commonly found as the strongest two predictors in the clinical model. The difference in motor threshold had greater importance than the absence or presence of motor evoked potential in the affected hemisphere. The various imaging metrics, including lesion overlap with the spinal cord, largely did not improve the model performance. The approach implemented here may enable clinicians to more accurately predict a chronic stroke patients individual response to intervention. The predictive models used in this study could assist clinicians in making treatment decisions and improve the accuracy of prognosis in chronic stroke patients.

neuroscience↗